First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
16.03
-0.34 (-2.08%)
At close: Jun 26, 2026, 4:00 PM EDT
16.03
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:34 PM EDT
TRAX Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for TRAX stock have an average target of 37.14, with a low estimate of 30 and a high estimate of 54. The average target predicts an increase of 131.69% from the current stock price of 16.03.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TRAX stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|
| Strong Buy | 4 | 4 | 5 |
| Buy | 2 | 3 | 3 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 6 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Initiates $30 | Buy | Initiates | $30 | +87.15% | Jun 8, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $31 → $30 | Buy | Maintains | $31 → $30 | +87.15% | May 23, 2026 |
| Wedbush | Wedbush | Buy Maintains $30 | Buy | Maintains | $30 | +87.15% | May 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $30 | Buy | Reiterates | $30 | +87.15% | May 15, 2026 |
| Barclays | Barclays | Buy Maintains $40 | Buy | Maintains | $40 | +149.53% | May 15, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.60
EPS Next Year
-3.14
from -3.60
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.30 | -2.28 | |
| Avg | -3.60 | -3.14 | |
| Low | -4.17 | -4.13 |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.